August 29, 2022
COVID trials at ESC 2022
Editor’s note, Oct. 10, 2022: The Lancet Respiratory Medicine published the ACT-inpatient and ACT-outpatient studies. As part of the Hot...
Read More
August 28, 2022
Largest RHD trial addressed AF & stroke risk in lower-income countries
The largest trial in patients with rheumatic heart disease (RHD) has found that in those patients with atrial fibrillation (AF),...
Read More
August 28, 2022
FX1a inhibitors tested in 2 stroke trials
PHRI researchers presented results from phase-2 stroke trials testing different orally active coagulation Factor X1a (FXIa) inhibitors in patients with...
Read More
August 26, 2022
Our global family in-person again!
The joy of in-person camaraderie and collaboration was apparent in everyone’s faces during two days of PHRI-hosted meetings with our...
Read More
August 23, 2022
Forging ahead – update on PHRI research
During the COVID-19 pandemic to date, PHRI has been forging ahead – completing major studies, publishing in high-impact journals, and...
Read More
August 22, 2022
Welcome to new researchers at PHRI
We are delighted to welcome a new Investigator and three new Research Fellows to PHRI! New Investigator, Rachel Eikelboom, is a...
Read More